Free Trial

Sharps Technology Q3 2023 Earnings Report

Sharps Technology logo
$0.36 -0.16 (-31.45%)
As of 02/21/2025 04:00 PM Eastern

Sharps Technology EPS Results

Actual EPS
-$3.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Sharps Technology Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sharps Technology Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Sharps Technology Earnings Headlines

The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond… It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest. It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground.
See More Sharps Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sharps Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sharps Technology and other key companies, straight to your email.

About Sharps Technology

Sharps Technology (NASDAQ:STSS), a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

View Sharps Technology Profile

More Earnings Resources from MarketBeat